DVRG.L Share News (DVRG)
DVRG Share
DVRG Share
DVRG Share
DVRG Share
DVRG
DVRG Share
DVRG Broker
DVRG Directors
DVRG Financial
DVRG
DVRG Short
DVRG
(Sharecast News) - DeepVerge updated the market on its operations on Monday, reporting that additional investment from its recent £10m placing had facilitated the completion of a laboratories upgrade in York, providing capacity for processing up to 20,000 'Skin Trust Club' home test kits each month for the UK market, subject only to delivery of gene sequencing machines, which was expected in early September.
Read more
UK shareholder meetings calendar - next 7 days
Read moreTRADING UPDATES: Inland Homes loss slims; Velocity outlook optimistic
Read moreTRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook
Read moreAIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact
Read moreEXECUTIVE CHANGES: Location Sciences gets new chair after fundraise
Read moreTRADING UPDATES: Superdry optimistic; Virgin Wines toasts demand surge
Read moreIN BRIEF: DeepVerge to form joint venture with China Resources
Read more(Sharecast News) - Environmental and life sciences artificial intelligence (AI) company DeepVerge has signed a non-binding memorandum of understanding with China Resources Environmental Protection Development , a wholly-owned subsidiary of China Resources, to enter into a joint venture for the manufacture, assembly and sale of environmental monitoring equipment.
Read moreIN BRIEF: DeepVerge launches customised skincare app
Read moreIN BRIEF: DeepVerge Chair Ross Andrews buys 150,000 shares
Read moreTRADING UPDATES: Arden Partners to return to annual profitability
Read more(Sharecast News) - Environmental and life sciences artificial intelligence (AI) company DeepVerge has signed a full technical and commercial agreement with Microsaic Systems, it announced on Wednesday.
Read moreTRADING UPDATES: Ceres Power eyes move to Main Market by mid-2022
Read more(Sharecast News) - Environmental and life science artificial intelligence company DeepVerge announced initial data for its ongoing phase 3 clinical studies on the detection of SARS-CoV-2 on breath samples, and the identification of confirmed COVID19 positive patients, on Wednesday.
Read more